DNA-based hybrid nanoparticles: from design to application in cancer therapy

Le Zhang; Zhuiyun Li; Wei Tan; C. Yao; Xiaocui Guo; Chao Zhang

doi:10.1039/d5bm01852h

January 1, 2026Biomaterials Science

DNA-based hybrid nanoparticles: from design to application in cancer therapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

To explore the design and application of DNA-based hybrid nanoparticles in cancer therapy.
Development of DNA scaffolds integrated with functional inorganic or organic components.
Evaluation of the hybrid systems' properties and effectiveness in targeting cancer cells.
Demonstrated enhanced targeting and delivery of therapeutic agents.
Potential for improved efficacy in cancer treatment compared to traditional methods.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Innovation in DNA-based hybrid nanoparticles shows promise in cancer therapy, suggesting new treatment options.

Abstract

Deoxyribonucleic acid (DNA)-based hybrid nanoparticles represent a cutting-edge class of advanced nanomaterials engineered by integrating functional inorganic or organic components with programmable DNA scaffolds. These hybrid systems synergistically combine the...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/699fe38b95ddcd3a253e773b https://doi.org/10.1039/d5bm01852h

View at Publisher

Ask AI

Bookmark

Share

DNA-based hybrid nanoparticles: from design to application in cancer therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

DNA-based hybrid nanoparticles: from design to application in cancer therapy

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading